Review Publications

The global challenge of new classes of antibacterial agents: an industry perspective

Prabhavathi Fernandes

Current Opinion in Pharmacology

Oct 2015, 24:7-11.

http://www.ncbi.nlm.nih.gov/pubmed/26119487

 

Investment in antibiotics against Pneumonia

Prabhavathi Fernandes

Lancet Infectious Diseases

April 2015  Vol. 15, pp.376

http://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(15)70057-5.pdf

 

Antibiotic Usage and the Development of Resistance 

David Oldach, Prabhavathi Fernandes

Clinical Infectious Diseases 

April 2015  Vol. 60, pp. 1139-1140

http://cid.oxfordjournals.org/content/60/7/1139.extract

 

Use of Antibiotic Core Structures to Generate New and Useful Macrolide Antibiotics

Prabhavathi Fernandes

Antibiotics: Current Innovations and Future Trends

January 2015.  Chapter 20: pp. 375-393

http://www.booksystemsplus.com/product.php?id_product=1256
 

Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections

P. Fernandes

Perspectives in Medicine: Antibiotics and Antibiotic Resistance. CSH book chapter.  January 2016

http://perspectivesinmedicine.cshlp.org/content/6/1/a025437.long

 

Headwinds into opportunity

P. Fernandes

Oct. 2011.  Nat Biotechnol. 29(10):864-6.

http://www.nature.com/nbt/journal/v29/n10/full/nbt1011-864.html